Full name
DENOVONED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 7 | 5,1 | 3,6 | -28 |
Gross profit (loss) | -2 | -2,1 | -1,6 | 22 |
EBITDA | -2 | -2,1 | -1,6 | 22 |
Net profit (loss) | -2 | -2,1 | -1,6 | 22 |
Cash | 7 | 5,1 | 3,6 | -28 |
Liabilities and provisions for liabilities | 0 | 0,1 | 0,3 | 200 |
Net income from sale | 0 | 0 | 0 | 0 |
Short time liabilities | 0 | 0 | 0 | 0 |
Working assets | 7 | 5,1 | 3,6 | -28 |
Equity capital | 7 | 5,1 | 3,6 | -28 |
Operating profit (EBIT) | -2 | -2,1 | -1,6 | 22 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -28,8 | -41 | -44,4 | -3,4 |
Equity capital to total assets | 100 | 100 | 100 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 0 | 0 |
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane